Rachel Meighan-Mantha
Principal Analyst
USA
+24 year(s) experience
Rachel began her time at Citeline as a drug specialist, managing Trialtrove’s auxiliary drug database. Since then, she has worked as an analyst specializing in autoimmune/inflammation drugs, immuno-oncology/immunotherapy, pharmacogenomic biomarkers, companion diagnostics, repurposing of drugs and regulatory approval pathways.
Before joining us, Rachel was a scientist in genetic and molecular toxicology for a global contract research organization. She also worked as an adjunct professor at two community colleges and as a research fellow in vascular biology, pharmacology and cancer biology.